Supplementary Material for: Changes in Tissue-Specific Innate Lymphoid Cell Populations during Rat Development by figshare admin karger (2628495)

Image2_Ghrelin is essential for lowering blood pressure during torpor.jpg by Kazuma Matsui (1368618)

“…Introduction<p>Daily torpor is an active hypothermic phenomenon that is observed in some mammals and birds during fasting. A decrease in blood pressure has also been observed in torpor; however, there remains a lack of knowledge of the underlying mechanism. …”

Image1_Ghrelin is essential for lowering blood pressure during torpor.jpeg by Kazuma Matsui (1368618)

“…Introduction<p>Daily torpor is an active hypothermic phenomenon that is observed in some mammals and birds during fasting. A decrease in blood pressure has also been observed in torpor; however, there remains a lack of knowledge of the underlying mechanism. …”

Crude Glycerin and Energy Density of Diets for Growing, Pre-Lay and Pre-Peak Backcob Brown Egg-Laying Hens by Y Avellaneda (10447248)

Divergent impact of actin isoforms on cell cycle regulation by Vera Dugina (5505281)

The expression of α7^GFP changes during different developmental stages of tooth development. by Scott W. Rogers (271631)

“…<p>A) Sagittal sections prepared of the E11.5 oral cavity shows α7^GFP expression, as detected by immunohistochemical staining for GFP expression, in the thickened dental lamina (asterisk) of the oral epithelium (ep) adjacent to or between developing tooth buds (tb). …”

Image_3_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

“…Lung tissue in the pneumonia model showed a 2.20 log CFU/g significant decrease in the ursolic acid methyl ester-treated group in comparison to the control group. …”

Table_2_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.doc by Rewan Abdelaziz (12961639)

“…Lung tissue in the pneumonia model showed a 2.20 log CFU/g significant decrease in the ursolic acid methyl ester-treated group in comparison to the control group. …”

Image_9_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

“…Lung tissue in the pneumonia model showed a 2.20 log CFU/g significant decrease in the ursolic acid methyl ester-treated group in comparison to the control group. …”

Image_10_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

“…Lung tissue in the pneumonia model showed a 2.20 log CFU/g significant decrease in the ursolic acid methyl ester-treated group in comparison to the control group. …”

Image_2_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

“…Lung tissue in the pneumonia model showed a 2.20 log CFU/g significant decrease in the ursolic acid methyl ester-treated group in comparison to the control group. …”

Image_1_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

“…Lung tissue in the pneumonia model showed a 2.20 log CFU/g significant decrease in the ursolic acid methyl ester-treated group in comparison to the control group. …”

Image_11_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

“…Lung tissue in the pneumonia model showed a 2.20 log CFU/g significant decrease in the ursolic acid methyl ester-treated group in comparison to the control group. …”

Image_7_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

“…Lung tissue in the pneumonia model showed a 2.20 log CFU/g significant decrease in the ursolic acid methyl ester-treated group in comparison to the control group. …”

Image_8_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

“…Lung tissue in the pneumonia model showed a 2.20 log CFU/g significant decrease in the ursolic acid methyl ester-treated group in comparison to the control group. …”

Image_6_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

“…Lung tissue in the pneumonia model showed a 2.20 log CFU/g significant decrease in the ursolic acid methyl ester-treated group in comparison to the control group. …”

Image_12_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

“…Lung tissue in the pneumonia model showed a 2.20 log CFU/g significant decrease in the ursolic acid methyl ester-treated group in comparison to the control group. …”

Image_13_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

“…Lung tissue in the pneumonia model showed a 2.20 log CFU/g significant decrease in the ursolic acid methyl ester-treated group in comparison to the control group. …”

Table_1_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.xlsx by Rewan Abdelaziz (12961639)

“…Lung tissue in the pneumonia model showed a 2.20 log CFU/g significant decrease in the ursolic acid methyl ester-treated group in comparison to the control group. …”

Data Sheet 1_Analysis and comparison of the trends in burden of spinal cord injury in China and worldwide from 1990 to 2021: an analysis of the global burden of disease study 2021.... by Hao Qin (113159)

“…Joinpoint analysis revealed a significant decrease in the APC of the age-standardized incidence rate (ASIR) from 1990 to 2011 (APC = −0.98, p < 0.05), followed by a notable increase from 2011 to 2021 (APC = 2.05, p < 0.05). …”